Sample Preparation in Global Metabolomics of Biological Fluids and Tissues - Proteomic and Metabolomic Approaches to Biomarker Discovery - page 74

biocompatible coatings for solid-phase micro-
extraction: implications for drug analysis and in vivo
sampling applications. Anal Chim Acta 2009; 638 (2):
175 e 85.
102. Vuckovic D, Gien B, de Lannoy I, Musteata FM,
Shirey R, Sidisky L, et al. In vivo solid-phase micro-
extraction for single rodent pharmacokinetics studies
of carbamazepine and carbamazpine- 10,11-epoxide in
mice. J Chromatogr A 2011; 1218 :3367 e 75.
103. Zhang X, Oakes KD, Cui S, Bragg L, Servos MR,
Pawliszyn J. Tissue-speci

metabonomic studies using UPLC combined with
orthogonal acceleration ToF-MS: effects of different
papers and sample storage stability. Bioanalysis 2011;
3 (24):2757 e 67.
109. Michopoulos F, Theodoridis G, Smith CJ, Wilson ID.
Metabolite pro uid spots for

metabonomic studies using UPLC combined with
oaToF-MS. J Proteome Res 2010; 9 (6):3328 e 34.
110. Wilson I. Global metabolic pro

les from dried bio

ling (metabonomics/
metabolomics) using dried blood spots: advantages
and pitfalls. Bioanalysis 2011; 3 (20):2255 e 7.
111. Smilde AK, Van Der Werf MJ, Schaller J,
Kistemaker C. Characterizing the precision of mass-
spectrometry-based metabolic pro

c in vivo bioaccumulation of
pharmaceuticals in rainbow trout (Oncorhynchus
mykiss) using space-resolved solid-phase micro-
extraction. Environ Sci Technol 2010; 44 (9):3417 e 22.
104. Musteata FM, de Lannoy I, Gien B, Pawliszyn J. Blood
sampling without blood draws for in vivo pharmaco-
kinetic studies in rats. J Pharm Biomed Anal 2008;
47 (4 e 5):907 e 12.
105. Michopoulos F, Edge AM, Theodoridis G, Wilson ID.
Application of turbulent

ling platforms.

Analyst 2009; 134 (11):2281 e 5.
112. Croixmarie V, Umbdenstock T, Cloarec O,
Moreau A, Pascussi JM, Boursier-Neyret C, et al.
Integrated comparison of drug-related and drug-
induced ultra performance liquid chromatography/
mass ow chromatography to the

metabonomic analysis of human plasma: Comparison
with protein precipitation. J Sep Sci 2010; 33 (10):1472 e 9.
106. Ceglarek U, Leichtle A, Brügel M, Kortz L, Brauer R,
Bresler K, et al. Challenges and developments in
tandem mass spectrometry based clinical metab-
olomics. Mol Cell Endocrinol 2009; 301 (1-2):266 e 71.
107. Kong ST, Lin H-, Ching J, Ho PC. Evaluation of dried
blood spots as sample matrix for gas chromatog-
raphy/mass

les using
human hepatocyte cultures. Anal Chem 2009; 81 (15):
6061 e 9.
113. Koek MM, Jellema RH, van der Greef J, Tas AC,
Hankemeier T. Quantitative metabolomics based on
gas chromatography mass spectrometry: status and
perspectives. Metabolomics 2011; 7 (3):307 e 28.
114. Guo K, Peng J, Zhou R, Li L. Ion-pairing reversed-
phase liquid chromatography fractionation in combi-
nation with isotope labeling reversed-phase liquid
chromatography-mass spectrometry for comprehen-
sive metabolome pro

spectrometry metabonomic pro

spectrometry based metabolomic

ling. Anal Chem 2011; 83 (11):4314 e 8.
108. Michopoulos F, Theodoridis G, Smith CJ, Wilson ID.
Metabolite pro

pro

ling. J Chromatogr A 2011;

les from dried blood spots for 1218 (23):3689 e 94.